ATPW
ARKG icon

Ashton Thomas Private Wealth’s ARK Genomic Revolution ETF ARKG Stock Holding History

Ashton Thomas Private Wealth’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-175
Closed -$4.11K – 694
2024
Q2 		$4.11K Buy
+175
New +$4.42K ﹤0.01% 1604

Other funds holding ARKG

BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
MMEA
Main Management ETF Advisors San Francisco, California $2.68B AUM 24.27% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Ashton Thomas Private Wealth's ARKG Position: Q3 2024 in Review

Ashton Thomas Private Wealth sold out of ARK Genomic Revolution ETF (ARKG) in Q3 2024, closing a stake of 175 shares — an estimated $4.11K sold.

Ashton Thomas Private Wealth first reported a position in ARKG in Q2 2024 and held it in 1 quarter. The position peaked at $4.11K in Q2 2024. 238 funds tracked by Wall St. Rank hold ARKG as of Q3 2024.

  • Ashton Thomas Private Wealth reported no remaining ARK Genomic Revolution ETF position as of Q3 2024 after selling out during the quarter.
  • Ashton Thomas Private Wealth sold 175 ARK Genomic Revolution ETF shares in Q3 2024, an estimated $4.11K.
  • Ashton Thomas Private Wealth first reported a position in ARK Genomic Revolution ETF in Q2 2024 and held it in 1 quarter.
  • Ashton Thomas Private Wealth's ARK Genomic Revolution ETF position peaked at $4.11K in Q2 2024.
  • 238 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2024.

Based on Ashton Thomas Private Wealth's 13F filing for Q3 2024, filed 5 Nov 2024.